X2U93YA
Supplement Atrium, Right to New Technology Group 10 with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | U Supplement |
| Body Part | 9 Atrium, Right |
| Approach | 3 Percutaneous |
| Device | Y Intraluminal Device, Heterotopic Bioprosthetic Valve(s) |
| Qualifier | A New Technology Group 10 |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
This family covers placing biological or synthetic material onto or into a cardiovascular structure to reinforce or augment its existing function, using a device or material that carries new technology status. Unlike a replacement, the native structure remains in place; the added material strengthens it, such as a novel reinforcing patch or scaffold applied to a heart valve or vessel wall to restore competency without removing the underlying tissue. This approach is often chosen when preserving the patient's own anatomy is preferable to a full replacement.
These procedures tend to be used in repair-oriented strategies, where surgeons aim to correct a structural deficiency, such as valve regurgitation, while conserving as much native tissue as possible.
Anatomy & Axis Detail
Atrium, Right
The right atrium receives deoxygenated systemic venous return and is the site of vascular access, cannulation, or congenital repair procedures during which its wall may require reinforcement. A Supplement coded here under New Technology reflects the application of a biologic or bioabsorbable patch material to strengthen or augment existing atrial tissue, for example reinforcing a septal repair, a cannulation site closure after mechanical circulatory support, or a suture line at risk of stress-related failure. Unlike Replacement, the native atrial wall remains in place with the new material layered onto or incorporated into it. Coding accuracy depends on confirming that the procedure adds supporting material to existing right atrial tissue rather than excising and substituting a portion of the chamber wall.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Intraluminal Device, Heterotopic Bioprosthetic Valve(s)
This value identifies a bioprosthetic valve, or set of valves, implanted in a heterotopic location, meaning a site outside the valve's normal anatomic position, such as within a large systemic vein to manage severe tricuspid regurgitation. It is distinguished from standard intraluminal bioprosthetic valves placed orthotopically in the native valve position. The heterotopic approach is chosen when direct native valve replacement is not feasible.
Qualifier: New Technology Group 10
New Technology Group 10 flags a procedure as part of the 2023 batch of add-on codes recognized under the New Technology section. The value itself carries no information about the device or drug involved; that comes from the table, body part, and approach values alongside it. Coders should not confuse it with Group 9 or Group 11, which cover the cohorts approved in the years immediately before and after.
Coding & Documentation
Coders should confirm the operative note describes the native structure remaining in place while the new material is added to reinforce or augment it, and that the specific product is named in the New Technology table. A common mistake is coding Supplement when the documentation actually supports Replacement because the native tissue was substantially excised, or missing the New Technology designation and defaulting to a standard section Supplement code. Precise identification of the body part being augmented also matters, since these codes are often anatomically specific to a single valve or vessel segment.